These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25430877)
1. Cannabinoid CB1 receptors mediate the effects of dipyrone. Crunfli F; Vilela FC; Giusti-Paiva A Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):246-55. PubMed ID: 25430877 [TBL] [Abstract][Full Text] [Related]
2. The role of endocannabinoid system and TRPV1 receptors in the antidepressant and anxiolytic effects of dipyrone in chronic unpredictable mild stress in mice. Topuz RD; Cetinkaya MZ; Erumit D; Duvan Aydemir K; Gunduz O; Karadag CH; Ulugol A Eur J Pharmacol; 2021 Oct; 908():174315. PubMed ID: 34270988 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid system involves in the analgesic effect of protocatechuic acid. Dikmen DY; Okcay Y; Arslan R; Bektas N Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037 [TBL] [Abstract][Full Text] [Related]
4. Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone. Elmas P; Ulugol A J Neural Transm (Vienna); 2013 Nov; 120(11):1533-8. PubMed ID: 23784345 [TBL] [Abstract][Full Text] [Related]
5. The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: neuronal K(ATP) channel opening and CB(1) receptor activation. dos Santos GG; Dias EV; Teixeira JM; Athie MC; Bonet IJ; Tambeli CH; Parada CA Eur J Pharmacol; 2014 Oct; 741():124-31. PubMed ID: 25058903 [TBL] [Abstract][Full Text] [Related]
6. Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice. Maione S; Radanova L; De Gregorio D; Luongo L; De Petrocellis L; Di Marzo V; Imming P Eur J Pharmacol; 2015 Feb; 748():115-22. PubMed ID: 25557763 [TBL] [Abstract][Full Text] [Related]
7. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the endogenous cannabinoid system in mediating the behavioral effects of dipyrone (metamizol) in mice. Schlosburg JE; Radanova L; Di Marzo V; Imming P; Lichtman AH Behav Pharmacol; 2012 Oct; 23(7):722-6. PubMed ID: 22954646 [TBL] [Abstract][Full Text] [Related]
9. Non-opioid Analgesics and the Endocannabinoid System. Topuz RD; Gündüz Ö; Karadağ ÇH; Ulugöl A Balkan Med J; 2020 Oct; 37(6):309-315. PubMed ID: 32551466 [TBL] [Abstract][Full Text] [Related]
10. The antinociceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors. Guindon J; LoVerme J; Piomelli D; Beaulieu P Anesth Analg; 2007 Jun; 104(6):1563-9, table of contents. PubMed ID: 17513659 [TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain. Sain NM; Liang A; Kane SA; Urban MO Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology of cannabinoid receptors and their ligands: an overview. Pertwee RG Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099 [TBL] [Abstract][Full Text] [Related]
13. Modulation by female sex hormones of the cannabinoid-induced catalepsy and analgesia in ovariectomized mice. Kalbasi Anaraki D; Sianati S; Sadeghi M; Ghasemi M; Paydar MJ; Ejtemaei Mehr S; Dehpour AR Eur J Pharmacol; 2008 May; 586(1-3):189-96. PubMed ID: 18371951 [TBL] [Abstract][Full Text] [Related]
14. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997 [TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide. Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201 [TBL] [Abstract][Full Text] [Related]
16. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940 [TBL] [Abstract][Full Text] [Related]
17. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833. Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650 [TBL] [Abstract][Full Text] [Related]
18. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats. Lee J; Di Marzo V; Brotchie JM Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299 [TBL] [Abstract][Full Text] [Related]
19. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes. Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016 [TBL] [Abstract][Full Text] [Related]
20. Divergent Response to Cannabinoid Receptor Stimulation in High and Low Stress-Induced Analgesia Mouse Lines Is Associated with Differential G-Protein Activation. Lesniak A; Chmielewska D; Poznanski P; Bujalska-Zadrozny M; Strzemecka J; Sacharczuk M Neuroscience; 2019 Apr; 404():246-258. PubMed ID: 30794845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]